1. Home
  2. FOLD
  3. FOLD News

Latest Amicus Therapeutics Inc. (FOLD) News on September 18, 2025

New 4-Year Data for Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) Presented at ICIEM
FOLD

GlobeNewswire

10 days ago

New 4-Year Data for Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) Presented at ICIEM

FOLD

MT Newswires

3 months ago

Amicus Therapeutics Says Japan Approval Received for Late-Onset Pompe Disease Treatment

Amicus Therapeutics Announces Approval of Pombiliti® (cipaglucosidase alfa) + Opfolda® (miglustat) in Japan
FOLD

GlobeNewswire

3 months ago

Amicus Therapeutics Announces Approval of Pombiliti® (cipaglucosidase alfa) + Opfolda® (miglustat) in Japan

Amicus Therapeutics Publishes Positive PROPEL Study Data for Pompe Disease Treatment
FOLD

Insider Monkey

3 months ago

Amicus Therapeutics Publishes Positive PROPEL Study Data for Pompe Disease Treatment

New Strong Sell Stocks for June 3rd
FOLD

Zacks

3 months ago

New Strong Sell Stocks for June 3rd

New Analysis of Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) Published in Muscle and Nerve
FOLD

GlobeNewswire

3 months ago

New Analysis of Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) Published in Muscle and Nerve

Amicus Therapeutics to Present at Upcoming Investor Conferences in June 2025
FOLD

GlobeNewswire

4 months ago

Amicus Therapeutics to Present at Upcoming Investor Conferences in June 2025

3 High Growth Tech Stocks In The US Market
FOLD

Simply Wall St.

4 months ago

3 High Growth Tech Stocks In The US Market

Is Amicus Therapeutics (FOLD) the Best Low Priced Biotech Stock to Buy Now?
FOLD

Insider Monkey

4 months ago

Is Amicus Therapeutics (FOLD) the Best Low Priced Biotech Stock to Buy Now?

Amicus Therapeutics to Present at the Bank of America 2025 Health Care Conference
FOLD

GlobeNewswire

4 months ago

Amicus Therapeutics to Present at the Bank of America 2025 Health Care Conference

Amicus Therapeutics First Quarter 2025 Earnings: Misses Expectations
FOLD

Simply Wall St.

4 months ago

Amicus Therapeutics First Quarter 2025 Earnings: Misses Expectations

FOLD Q1 Earnings and Sales Miss Estimates, Stock Falls
FOLD

Zacks

5 months ago

FOLD Q1 Earnings and Sales Miss Estimates, Stock Falls

FOLD

MT Newswires

5 months ago

UBS Adjusts Amicus Therapeutics Price Target to $22 From $21, Maintains Buy Rating

Dimerix and Amicus to commercialise DMX-200 in US
FOLD

Pharmaceutical Technology

5 months ago

Dimerix and Amicus to commercialise DMX-200 in US

FOLD

MT Newswires

5 months ago

Amicus Therapeutics Turns to Non-GAAP Q1 Earnings, Revenue Rises; Shares Down

Amicus Therapeutics (FOLD) Q1 Earnings and Revenues Lag Estimates
FOLD

Zacks

5 months ago

Amicus Therapeutics (FOLD) Q1 Earnings and Revenues Lag Estimates

FOLD

Associated Press Finance

5 months ago

Amicus Therapeutics: Q1 Earnings Snapshot

Amicus Therapeutics Announces First Quarter 2025 Financial Results and Corporate Updates
FOLD

GlobeNewswire

5 months ago

Amicus Therapeutics Announces First Quarter 2025 Financial Results and Corporate Updates

FOLD

MT Newswires

5 months ago

Amicus Therapeutics Signs Exclusive License Deal for Dimerix Kidney Disease Therapy

Dimerix and Amicus Therapeutics Announce Exclusive License Agreement for DMX-200 in the United States
FOLD

GlobeNewswire

5 months ago

Dimerix and Amicus Therapeutics Announce Exclusive License Agreement for DMX-200 in the United States

Earnings Preview: Y-mAbs Therapeutics, Inc. (YMAB) Q1 Earnings Expected to Decline
FOLD

Zacks

5 months ago

Earnings Preview: Y-mAbs Therapeutics, Inc. (YMAB) Q1 Earnings Expected to Decline

Amicus Therapeutics (FOLD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
FOLD

Zacks

5 months ago

Amicus Therapeutics (FOLD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Is Amicus Therapeutics, Inc. (FOLD) Among the Best Guru Stocks to Buy According to Wall Street Analysts?
FOLD

Insider Monkey

5 months ago

Is Amicus Therapeutics, Inc. (FOLD) Among the Best Guru Stocks to Buy According to Wall Street Analysts?

Amicus Therapeutics to Report Q1 Earnings: What's in the Cards?
FOLD

Zacks

5 months ago

Amicus Therapeutics to Report Q1 Earnings: What's in the Cards?

Amicus Therapeutics to Announce First Quarter 2025 Financial Results on May 1, 2025
FOLD

GlobeNewswire

5 months ago

Amicus Therapeutics to Announce First Quarter 2025 Financial Results on May 1, 2025

Is ​​Amicus Therapeutics, Inc. (FOLD) the Best Low Priced Growth Stock To Invest In?
FOLD

Insider Monkey

5 months ago

Is ​​Amicus Therapeutics, Inc. (FOLD) the Best Low Priced Growth Stock To Invest In?

Analysts Expect Amicus Therapeutics, Inc. (NASDAQ:FOLD) To Breakeven Soon
FOLD

Simply Wall St.

5 months ago

Analysts Expect Amicus Therapeutics, Inc. (NASDAQ:FOLD) To Breakeven Soon

Is Amicus Therapeutics, Inc. (FOLD) the Best Low Cost Stock to Buy According to Billionaires?
FOLD

Insider Monkey

5 months ago

Is Amicus Therapeutics, Inc. (FOLD) the Best Low Cost Stock to Buy According to Billionaires?

Amicus Therapeutics (FOLD) Up 0.1% Since Last Earnings Report: Can It Continue?
FOLD

Zacks

6 months ago

Amicus Therapeutics (FOLD) Up 0.1% Since Last Earnings Report: Can It Continue?

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
FOLD

Zacks

6 months ago

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

Is Amicus Therapeutics Inc. (FOLD) the Best Nasdaq Stock Under $20 to Buy Now?
FOLD

Insider Monkey

6 months ago

Is Amicus Therapeutics Inc. (FOLD) the Best Nasdaq Stock Under $20 to Buy Now?

Amicus Therapeutics, Inc. (FOLD): Among the Stocks Under $10 With High Upside Potential
FOLD

Insider Monkey

6 months ago

Amicus Therapeutics, Inc. (FOLD): Among the Stocks Under $10 With High Upside Potential

US High Growth Tech Stocks With Strong Potential
FOLD

Simply Wall St.

7 months ago

US High Growth Tech Stocks With Strong Potential

Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2025
FOLD

GlobeNewswire

7 months ago

Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2025

Why Amicus Therapeutics, Inc. (FOLD) is the Most Oversold Pharma Stock to Buy According to Analysts
FOLD

Insider Monkey

7 months ago

Why Amicus Therapeutics, Inc. (FOLD) is the Most Oversold Pharma Stock to Buy According to Analysts

FOLD's Q4 Earnings Miss, Higher Product Sales Drive Revenue Growth
FOLD

Zacks

7 months ago

FOLD's Q4 Earnings Miss, Higher Product Sales Drive Revenue Growth

Compared to Estimates, Amicus Therapeutics (FOLD) Q4 Earnings: A Look at Key Metrics
FOLD

Zacks

7 months ago

Compared to Estimates, Amicus Therapeutics (FOLD) Q4 Earnings: A Look at Key Metrics

Amicus Therapeutics Full Year 2024 Earnings: EPS Beats Expectations
FOLD

Simply Wall St.

7 months ago

Amicus Therapeutics Full Year 2024 Earnings: EPS Beats Expectations

Amicus Therapeutics Inc (FOLD) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...
FOLD

GuruFocus.com

7 months ago

Amicus Therapeutics Inc (FOLD) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

FOLD

Thomson Reuters StreetEvents

7 months ago

Q4 2024 Amicus Therapeutics Inc Earnings Call

Amicus Therapeutics (FOLD) Q4 Earnings and Revenues Miss Estimates
FOLD

Zacks

7 months ago

Amicus Therapeutics (FOLD) Q4 Earnings and Revenues Miss Estimates

FOLD

MT Newswires

7 months ago

Amicus Therapeutics' Q4 Non-GAAP Earnings, Net Product Revenue Rise

Amicus Therapeutics Announces Full-Year 2024 Financial Results and Corporate Updates
FOLD

GlobeNewswire

7 months ago

Amicus Therapeutics Announces Full-Year 2024 Financial Results and Corporate Updates

Will These 5 Biotech Stocks Surpass Q4 Earnings Forecast?
FOLD

Zacks

7 months ago

Will These 5 Biotech Stocks Surpass Q4 Earnings Forecast?

Insights Into Amicus Therapeutics (FOLD) Q4: Wall Street Projections for Key Metrics
FOLD

Zacks

7 months ago

Insights Into Amicus Therapeutics (FOLD) Q4: Wall Street Projections for Key Metrics

Travere Therapeutics (TVTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
FOLD

Zacks

7 months ago

Travere Therapeutics (TVTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Amicus Therapeutics (FOLD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
FOLD

Zacks

7 months ago

Amicus Therapeutics (FOLD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Amicus Therapeutics to Announce Full-Year 2024 Financial Results on February 19, 2025
FOLD

GlobeNewswire

7 months ago

Amicus Therapeutics to Announce Full-Year 2024 Financial Results on February 19, 2025

Amicus Therapeutics Announces Presentations and Posters at the 21st Annual WORLDSymposium™ 2025
FOLD

GlobeNewswire

7 months ago

Amicus Therapeutics Announces Presentations and Posters at the 21st Annual WORLDSymposium™ 2025

Is Amicus Therapeutics (FOLD) Among Billionaire Joseph Edelman’s Long-Term Stock Picks?
FOLD

Insider Monkey

8 months ago

Is Amicus Therapeutics (FOLD) Among Billionaire Joseph Edelman’s Long-Term Stock Picks?

Amicus Therapeutics, Inc. (FOLD): The Biotech Stock with Biggest Upside Potential
FOLD

Insider Monkey

8 months ago

Amicus Therapeutics, Inc. (FOLD): The Biotech Stock with Biggest Upside Potential

Amicus Posts Preliminary 2024 Results, Issues 2025 Outlook
FOLD

Zacks

8 months ago

Amicus Posts Preliminary 2024 Results, Issues 2025 Outlook

Shareholders in Amicus Therapeutics (NASDAQ:FOLD) have lost 32%, as stock drops 3.0% this past week
FOLD

Simply Wall St.

8 months ago

Shareholders in Amicus Therapeutics (NASDAQ:FOLD) have lost 32%, as stock drops 3.0% this past week

FOLD

MT Newswires

8 months ago

Amicus Therapeutics Reports Preliminary Q4 Revenue

Amicus Therapeutics Reports Preliminary 2024 Revenue and Provides 2025 Strategic Outlook
FOLD

GlobeNewswire

8 months ago

Amicus Therapeutics Reports Preliminary 2024 Revenue and Provides 2025 Strategic Outlook

Is Amicus Therapeutics (FOLD) the Best Medical Stock to Buy Under $20?
FOLD

Insider Monkey

8 months ago

Is Amicus Therapeutics (FOLD) the Best Medical Stock to Buy Under $20?

Amicus Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
FOLD

GlobeNewswire

9 months ago

Amicus Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

HALO or FOLD: Which Is the Better Value Stock Right Now?
FOLD

Zacks

9 months ago

HALO or FOLD: Which Is the Better Value Stock Right Now?

Why Are Amicus, Immunocore, & Immuneering Stocks Trading Lower On Friday?
FOLD

Benzinga

9 months ago

Why Are Amicus, Immunocore, & Immuneering Stocks Trading Lower On Friday?

Amicus Therapeutics (FOLD) is a Top-Ranked Momentum Stock: Should You Buy?
FOLD

Zacks

9 months ago

Amicus Therapeutics (FOLD) is a Top-Ranked Momentum Stock: Should You Buy?

FOLD

MT Newswires

9 months ago

Morgan Stanley Downgrades Amicus Therapeutics to Equalweight From Overweight, Cuts Price Target to $12 From $17

Why Is Amicus Therapeutics (FOLD) Down 11.1% Since Last Earnings Report?
FOLD

Zacks

9 months ago

Why Is Amicus Therapeutics (FOLD) Down 11.1% Since Last Earnings Report?

HALO vs. FOLD: Which Stock Is the Better Value Option?
FOLD

Zacks

9 months ago

HALO vs. FOLD: Which Stock Is the Better Value Option?

Exploring High Growth Tech Stocks In The United States December 2024
FOLD

Simply Wall St.

10 months ago

Exploring High Growth Tech Stocks In The United States December 2024

HALO vs. FOLD: Which Stock Should Value Investors Buy Now?
FOLD

Zacks

10 months ago

HALO vs. FOLD: Which Stock Should Value Investors Buy Now?

Amicus Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
FOLD

Simply Wall St.

10 months ago

Amicus Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Amicus' Q3 Earnings & Revenues Beat Estimates, '24 View Updated
FOLD

Zacks

10 months ago

Amicus' Q3 Earnings & Revenues Beat Estimates, '24 View Updated

Here's Why Amicus Therapeutics (FOLD) is a Strong Momentum Stock
FOLD

Zacks

10 months ago

Here's Why Amicus Therapeutics (FOLD) is a Strong Momentum Stock

Amicus Therapeutics Inc (FOLD) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...
FOLD

GuruFocus.com

10 months ago

Amicus Therapeutics Inc (FOLD) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...

FOLD

Thomson Reuters StreetEvents

10 months ago

Q3 2024 Amicus Therapeutics Inc Earnings Call

Here's What Key Metrics Tell Us About Amicus Therapeutics (FOLD) Q3 Earnings
FOLD

Zacks

10 months ago

Here's What Key Metrics Tell Us About Amicus Therapeutics (FOLD) Q3 Earnings

Amicus Therapeutics (FOLD) Q3 Earnings and Revenues Beat Estimates
FOLD

Zacks

10 months ago

Amicus Therapeutics (FOLD) Q3 Earnings and Revenues Beat Estimates

FOLD

MT Newswires

10 months ago

Amicus Therapeutics Swings to Q3 Non-GAAP Net Income, Sales Gain; Raises 2024 Revenue Growth Guidance; Shares Rise Pre-Bell

FOLD

Associated Press Finance

10 months ago

Amicus Therapeutics: Q3 Earnings Snapshot

Amicus Therapeutics Announces Third Quarter 2024 Financial Results and Corporate Updates
FOLD

GlobeNewswire

10 months ago

Amicus Therapeutics Announces Third Quarter 2024 Financial Results and Corporate Updates

Wall Street Analysts Predict a 51.09% Upside in Amicus Therapeutics (FOLD): Here's What You Should Know
FOLD

Zacks

10 months ago

Wall Street Analysts Predict a 51.09% Upside in Amicus Therapeutics (FOLD): Here's What You Should Know

Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2024
FOLD

GlobeNewswire

a year ago

Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2024

Will Mirum Pharmaceuticals, Inc. (MIRM) Report Negative Q3 Earnings? What You Should Know
FOLD

Zacks

a year ago

Will Mirum Pharmaceuticals, Inc. (MIRM) Report Negative Q3 Earnings? What You Should Know

Amicus Therapeutics (FOLD) Reports Next Week: Wall Street Expects Earnings Growth
FOLD

Zacks

a year ago

Amicus Therapeutics (FOLD) Reports Next Week: Wall Street Expects Earnings Growth

Amicus Therapeutics to Announce Third Quarter 2024 Financial Results on November 6, 2024
FOLD

GlobeNewswire

a year ago

Amicus Therapeutics to Announce Third Quarter 2024 Financial Results on November 6, 2024

GitLab and Baidu have been highlighted as Zacks Bull and Bear of the Day
FOLD

Zacks

a year ago

GitLab and Baidu have been highlighted as Zacks Bull and Bear of the Day

Best Momentum Stocks to Buy for October 24th
FOLD

Zacks

a year ago

Best Momentum Stocks to Buy for October 24th

Why Amicus Therapeutics (FOLD) is a Top Momentum Stock for the Long-Term
FOLD

Zacks

a year ago

Why Amicus Therapeutics (FOLD) is a Top Momentum Stock for the Long-Term

Can Amicus Therapeutics (FOLD) Run Higher on Rising Earnings Estimates?
FOLD

Zacks

a year ago

Can Amicus Therapeutics (FOLD) Run Higher on Rising Earnings Estimates?

FOLD Stock Rises on Settling Galafold Patent Dispute With Teva
FOLD

Zacks

a year ago

FOLD Stock Rises on Settling Galafold Patent Dispute With Teva

How Much Upside is Left in Amicus Therapeutics (FOLD)? Wall Street Analysts Think 43.44%
FOLD

Zacks

a year ago

How Much Upside is Left in Amicus Therapeutics (FOLD)? Wall Street Analysts Think 43.44%

Amicus Therapeutics (FOLD) Just Flashed Golden Cross Signal: Do You Buy?
FOLD

Zacks

a year ago

Amicus Therapeutics (FOLD) Just Flashed Golden Cross Signal: Do You Buy?

Amicus Therapeutics (FOLD) Stock Jumps 14.0%: Will It Continue to Soar?
FOLD

Zacks

a year ago

Amicus Therapeutics (FOLD) Stock Jumps 14.0%: Will It Continue to Soar?

FOLD

MT Newswires

a year ago

Update: Amicus Therapeutics Shares Surge After Settling Patent Suit Against Teva Pharmaceuticals With License Deal

Amicus Therapeutics Settles Patent Lawsuit Teva Pharmaceuticals Over Generic Version Of Its Rare Genetic Disorder Drug
FOLD

Benzinga

a year ago

Amicus Therapeutics Settles Patent Lawsuit Teva Pharmaceuticals Over Generic Version Of Its Rare Genetic Disorder Drug

FOLD

MT Newswires

a year ago

Amicus Therapeutics Settles Patent Suit Against Teva Pharmaceuticals with License Agreement

Amicus Therapeutics Announces Settlement of Galafold® (migalastat) Patent Litigation with Teva
FOLD

GlobeNewswire

a year ago

Amicus Therapeutics Announces Settlement of Galafold® (migalastat) Patent Litigation with Teva

Exploring Three High Growth Tech Stocks in the United States
FOLD

Simply Wall St.

a year ago

Exploring Three High Growth Tech Stocks in the United States

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Is Expected To Breakeven In The Near Future
FOLD

Simply Wall St.

a year ago

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Is Expected To Breakeven In The Near Future

Amicus Therapeutics Inc (FOLD) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and ...
FOLD

GuruFocus.com

a year ago

Amicus Therapeutics Inc (FOLD) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and ...

JPMorgan Chase & Co's Strategic Reduction in Amicus Therapeutics Inc
FOLD

GuruFocus.com

a year ago

JPMorgan Chase & Co's Strategic Reduction in Amicus Therapeutics Inc

Amicus Therapeutics Announces Participation at the World Muscle Society Annual Congress 2024
FOLD

GlobeNewswire

a year ago

Amicus Therapeutics Announces Participation at the World Muscle Society Annual Congress 2024

Is Amicus Therapeutics, Inc. (FOLD) the Best Guru Stock To Buy Now?
FOLD

Insider Monkey

a year ago

Is Amicus Therapeutics, Inc. (FOLD) the Best Guru Stock To Buy Now?

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
FOLD

Zacks

a year ago

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

FOLD

MT Newswires

a year ago

Jefferies Initiates Amicus Therapeutics at Buy

Share on Social Networks: